Regarding the different stages of the disease, the highest level of lncRNA GAS5 was observed in cirrhosis (5.13 ± 0.17), NASH (4.1 ± 0.1), and simple steatosis (3.18 ± 0.62) (p < 0.001, Figure 1). Here, GAS5 is linked to metabolic dysfunction-associated steatohepatitis.